Skip to Content
Find MS events and support groups near you! Get started >>

Fospropofol Pregnancy and Breastfeeding Warnings

Fospropofol is also known as: Lusedra

Fospropofol Pregnancy Warnings

-Animal studies of high doses have failed to reveal evidence of teratogenicity or impairment of fertility; however high doses did show maternal toxicity. There are no controlled data in human pregnancy -This drug is not recommended for use in labor and delivery, including Cesarean section deliveries. It is not known if it crosses the placenta; however, propofol is known to cross the placenta, and as with other sedative-hypnotic agents, administration may be associated with neonatal respiratory and cardiovascular depression. US FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.

This drug should be used during pregnancy only if the benefit outweighs the risk. US FDA pregnancy category: B

See references

Fospropofol Breastfeeding Warnings

Use is not recommended. Excreted into human milk: Unknown Excreted into animal milk: Yes Comment: -The effects in the nursing infant are unknown.

-No information is available on the clinical use of this drug during breastfeeding; however, it is rapidly metabolized to propofol in the body. Amounts of propofol in milk are very small and are not expected to be absorbed by the infant; however, some experts recommend withholding nursing for an unspecified time after administration, and resuming as soon as the mother has recovered sufficiently from general anesthesia to nurse and that discarding milk is unnecessary. -When a combination of anesthetic agents is used for a procedure, the recommendations for the most problematic medication used during the procedure should be followed.

See references

References for pregnancy information

  1. "Product Information. Lusedra (fospropofol)." Eisai Inc, Teaneck, NJ.

References for breastfeeding information

  1. "Product Information. Lusedra (fospropofol)." Eisai Inc, Teaneck, NJ.
  2. United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT." ([cited 2013 -]):

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide